171 related articles for article (PubMed ID: 31428374)
1. Acute autoimmune myocarditis as a manifestation of Graves' disease: A case report and review of the literature.
Lancaster ST; Koons KL; Lee YJ; Mazimba S; Kwon Y
Clin Case Rep; 2019 Aug; 7(8):1489-1493. PubMed ID: 31428374
[TBL] [Abstract][Full Text] [Related]
2. Acute myocarditis presenting as accelerated junctional rhythm in Graves' disease: A case report.
Li MM; Liu WS; Shan RC; Teng J; Wang Y
World J Clin Cases; 2021 Dec; 9(35):11085-11094. PubMed ID: 35047622
[TBL] [Abstract][Full Text] [Related]
3. [Acute autoimmune myocarditis secondary to Graves' disease: a case report].
Demoulin R; Poyet R; Parsai C; Capilla E; Rohel G; Pons F; Jego C; Cellarier GR
Rev Med Interne; 2020 Mar; 41(3):206-209. PubMed ID: 31982255
[TBL] [Abstract][Full Text] [Related]
4. Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.
Wu L; Wang W; Leng Q; Tang N; Zhou N; Wang Y; Wang DW
Front Cardiovasc Med; 2021; 8():678645. PubMed ID: 34307494
[TBL] [Abstract][Full Text] [Related]
5. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
6. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis.
Patrizio A; Viva T; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A; Fallahi P
Autoimmun Rev; 2023 Feb; 22(2):103238. PubMed ID: 36436749
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating antibodies in patients with autoimmune disorders.
Strakosch CR; Joyner D; Wall JR
J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
10. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
[TBL] [Abstract][Full Text] [Related]
11. Preclinical models of Graves' disease and associated secondary complications.
Moshkelgosha S; So PW; Diaz-Cano S; Banga JP
Curr Pharm Des; 2015; 21(18):2414-21. PubMed ID: 25777757
[TBL] [Abstract][Full Text] [Related]
12. Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature.
Brancatella A; Viola N; Brogioni S; Montanelli L; Sardella C; Vitti P; Marcocci C; Lupi I; Latrofa F
Eur Thyroid J; 2019 Jul; 8(4):192-195. PubMed ID: 31602361
[TBL] [Abstract][Full Text] [Related]
13. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
14. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.
Sabini E; Ionni I; Rocchi R; Vitti P; Marcocci C; Marinò M
Eur Thyroid J; 2018 Jan; 7(1):51-54. PubMed ID: 29594055
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
Bunevicius R; Prange AJ
CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
[TBL] [Abstract][Full Text] [Related]
17. Unexpected case of Graves` disease induced myocarditis: a case report.
Safitri W; Hasanah DY; Atmadikoesoemah CA; Mahavira A
Cardiovasc Endocrinol Metab; 2024 Mar; 13(1):e0297. PubMed ID: 38213667
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
19. Fluctuating Hyperthyroidism and Hypothyroidism in Graves' Disease: The Swinging Between Two Clinical Entities.
Shrestha A; Adhikari N; Devkota S; Chowdhury T; Shiferaw-Deribe Z; Gousy N; Adhikari S
Cureus; 2022 Aug; 14(8):e27715. PubMed ID: 36081960
[TBL] [Abstract][Full Text] [Related]
20. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
Lohiya S; Lohiya V; Stahl EJ
Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
